Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Dr Reddy's Laboratories has launched Atocor-R in India. It is the first such combination to be approved by the Drugs Controller General of India and has completed a multicentre clinical trial data on Indian patients.
Subscribe to our email newsletter
It is a one of its kind combination that has two blockbuster molecules, Atorvastatin and Ramipril combined together for the first time as a fixed dose combination. Atocor-R is used in the treatment of patients with both essential hypertension and hypercholesterolemia.
It is available in two fixed dose combinations of Atocor-R 2.5 (Atorvastatin 10mg + Ramipril 2.5mg ) and Atocor-R 5 (Atorvastatin 10mg + ramipril 5mg) and comes is packs of 10.